陇西县中药材种植业发展研究

陇西县凭借得天独厚的生产条件和气候环境,不断扩大中药材种植面积,增加种植品种,种植效益日益显著。本文结合陇西县实际情况,从陇西县中药材种植业发展现状着手,分析中药材种植中存在的问题,为进一步提高中药材种植水平提出了相关对策和建议。     

保护中医药市场,要加强传统中药在基层的落实

本文从中医药市场日益萎缩的现状出发,分析在基层应该加强落实传统中药。     

浅析中医药在国际销售市场中的现状与前景

随着针炙在世界的普及,中医药在世界各国,特别是在发达国家日益受到欢迎。中医药将迅速走向世界,造福全人类,成为与西医药平起平坐、相互补充而又不能相互取代的人类另一医疗保健体系。现西方草药市场巨大,是对中医药极富吸引力的新市场。香港的中药市场是随着我国内地的政治、经济发展处于不断的变化之中。开拓日本中药材,特别是草药市场大有可为。中药必须走现代化和科技创新之路。     

Limits to forecasting in personalized medicine: An overview

Biomedical research is generating massive amounts of information about potential prognostic factors for health and disease. However, few prognostic factors or systems are robustly validated, and still fewer have made a convincing difference in health outcomes or in prolonging life expectancy. For most diseases and outcomes, a considerable component of the prognostic variance remains unknown, and may remain so for the foreseeable future. I discuss here some of the main problems in medical forecasting that pose obstacles to personalized medicine. Their recognition may help identify solutions to improve personalized prognosis, or at least understand and cope with the component of the future that we cannot predict. Much prognostic research is stuck at generating “publishable units”, without any interest in conclusively proving their worth, let alone moving them into real life applications. Information is reported selectively and reporting is deficient. The replication record of prognostic claims is poor. Even among replicated prognostic effects, few are convincingly shown to add much information besides what is already known through more simple, traditional measurements. There are few efforts to systematize prognostic knowledge. Most prognostic effects are subtle when traced to the molecular level, where most current research operates. Many researchers, clinicians, and the public are not appropriately educated to interpret prognostic information. We still have not even agreed on what the important health outcomes are that we want to predict and intervene for, and some subjectivity may be unavoidable. Finally, without concomitant effective, affordable, and non-harmful interventions, prognosis alone is of questionable value, and wrong prognosis or a wrong interpretation thereof can be harmful. The identification of these problems also suggests a roadmap on what could be done to amend them. Solutions include a systematic approach to the design, conduct, reporting, replication, and clinical translation of prognostic research; as well as the education of researchers, clinicians, and the general public. Finally, we need to recognize that perfect individualized health forecasting is not a realistic target in the foreseeable future, and we have to live with considerable residual uncertainty.     

我国生物医药行业发展问题的思考

生物医药行业是生物工程产业的重要支柱 ,本文针对我国生物医药行业存在的主要问题进行分析 ,并提出解决问题的具体对策。     

智能自助售药设备的研究与应用

近些年来,为了改善我国医疗系统就诊密度大,看病买药难的问题,政府出台了一系列的政策措施,鼓励并引导人们就近在社区医院或门诊看病购药。自助售药机作为一种新型自助服务终端,在结合了物联网、大数据等技术后,可节省医院一部分医疗资源,实现患者自主问诊取方购药,有效的缓解了我国现行医疗资源紧张的现象。该文以几种最新出现的智能自助售药设备作为研究对象,通过对其功能特点进行详细阐述,分析了各类自助售药设备的结构模块和工作原理,并对可能存在的问题提出了一些看法,最后针对未来智能自助售药设备的发展前景进行了探讨与展望。     

基于专利强度分析的区域中药材产业创新水平评价

中药材产业创新能力是中医药事业高质量传承发展的保障。以2009-2018年中国中药材产业已授权发明专利为研究对象。首先构建10个可量化的专利强度评价指标,用CRITIC赋权法对专利指标进行赋权,计算单个专利的专利强度。然后用正态分布函数划分专利强度等级,计算全国各省份的专利强度等级占比。最后以专利强度等级占比情况凸显产业创新发展水平,发现沿海以及围绕直辖市的省份的中药材产业创新发展水平良好,西部欠发达地区创新水平还有很大的发展空间,说明中药材产业创新发展能力与资源分配和经济发展有很大的关系。     

长三角医药制造业上市公司动态竞争力研究

基于企业竞争力基本理论提出了上市公司动态竞争力的评价指标体系。运用集对同一度分析和因子分析对长三角17家医药制造业上市公司的竞争力进行了实证研究。得出了各上市公司动态竞争力的排序,同时总结了各上市公司在市场盈利、资产结构、组织运营、科技创新各方面的优劣,以及不同因素对公司动态竞争力影响的程度。     

An investigation on traditional Chinese medicine in Dublin Ireland

The traditional Chinese medicine chain arrived in Ireland in 2005. This study focused on the standardization and adaptation of TCM companies and the customer profile in Irish market. The objective of this research dissertation is to find that how TCM is learned in Irish market and how it faces different cultures.     

转化医学团队构建的经济学分析

加快转化医学发展,促进医学模式转变是医学研究发展的必然趋势。转化医学团队是联系基础医学和临床实践的纽带,根据转化医学的特点,从经济学的角度分析转化医学团队构建中的若干关系,据此提出有利于团队构建的建议,鼓励科研人员组建转化医学团队的积极性。